Upadoz 30mg Tablet (Upadacitinib)
Medicine OverView
Rheumatoid Arthritis • Psoriatic Arthritis • Atopic Dermatitis • Targeted Immunotherapy
Upadacitinib 30mg Tablet is a prescription medicine belonging to the class of Janus Kinase (JAK) inhibitors. It is used in the treatment of various autoimmune and inflammatory conditions where the immune system becomes overactive and attacks healthy tissues.
It works by selectively inhibiting JAK1 enzymes, reducing inflammation, pain, swelling, and tissue damage in chronic autoimmune diseases. This targeted mechanism helps improve symptoms while slowing disease progression.
It is commonly prescribed in patients who do not respond adequately to traditional disease-modifying antirheumatic drugs (DMARDs).
Upadacitinib 30mg Tablet is used for the management of several chronic autoimmune conditions, including:
It helps reduce joint damage, skin inflammation, itching, stiffness, and long-term disability caused by autoimmune disease activity.
Upadacitinib works by blocking the activity of Janus Kinase 1 (JAK1), an enzyme involved in the inflammatory signaling pathway.
By inhibiting JAK1, it reduces the release of inflammatory cytokines responsible for pain, swelling, and immune system overactivity.
The dosage of Upadacitinib 30mg Tablet is strictly determined by the doctor based on disease severity and patient response.
Important: Regular monitoring is required during long-term therapy.
Serious side effects are rare but may include infections due to immune suppression.
Upadacitinib may interact with:
Upadacitinib 30mg Tablet is an advanced targeted therapy used for chronic autoimmune diseases. It helps control inflammation, reduce symptoms, and improve daily functioning in patients with moderate to severe conditions.
It should always be used under specialist supervision for safe and effective long-term management.
What do you think about this product?